Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Asia Financial Holdings Limited (0662.HK)
Central, HK
Asia Financial Holdings Limited specializes in offering both general and life insurance coverage within the regions of Hong Kong, Macau, and Mainland China. Its operational structure is divided into two primary segments: Insurance and Corporate. Beyond its core insurance business, the company also engages in the trading and holding of securities, provides financing for mortgage loans, acts as a nominee, and offers various healthcare services. Furthermore, it actively participates in real estate investment ventures. Established in 1991, the firm's principal office is situated in Central, Hong Kong. Asia Financial Holdings Limited operates as a subsidiary of Claremont Capital Holdings Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.84% | +3.62% | +4.06% | +1.46% | -0.61% | +1.46% | +22.06% | +45.37% | +31.62% | +10.43% | +260.74% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Life: +10.6%+36.5% ★ Q4'25: +34.2% (vs Q4'23)
-
EPS growth Insurance - Life: +13.4%+62.9% ★ Q4'25: +1,243.9% (vs Q4'23)
-
FCF margin FCF growth · Insurance - Life: +31.7%+13.9% Q4'25: +28.6% (vs Q4'23)
-
EBIT margin Insurance - Life: +12.4%+28.3% ★ Q4'25: +28.6% (vs Q4'23)
-
ROIC Insurance - Life: +1.0%+9.8% ★ Q4'25: +21.1% (vs Q4'23)
-
Share dilution Insurance - Life: +0.4%-0.4% Q4'25: -0.5% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Life: -1.05×0.00× ★ Q4'25: 0.00× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-26 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-18 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-15 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-14 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-05 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 3/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 4/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Charnwut Chan | Executive Chairman & President | 14M | — |
| Kok Wong | Executive Director | 4M | male |
| Stephen Tan | Executive Director | 4M | male |
| Chiu Cheung Ma | Advisor | 110.0K | male |
| Shirley Kwok | Vice President & Head of Corporate Affairs | — | — |
| Stephanie Tan | Executive Vice President | — | female |
| Yuet Wah Chiang | Executive Vice President, Company Secretary & Compliance Officer | — | female |
| James Lee | Executive Vice President & Head of Group Investment | — | — |
| Karen Ko | Senior Executive Vice President & Chief Operating Officer | — | female |
| Michael Foo | Executive Vice President, Head of Group Internal Audit & Chief Risk Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 0662.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
